Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Assets Average: 2018-2025

Historic Assets Average for Neurogene (NGNE) over the last 6 years, with Sep 2025 value amounting to $292.6 million.

  • Neurogene's Assets Average rose 70.13% to $292.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.6 million, marking a year-over-year increase of 70.13%. This contributed to the annual value of $279.2 million for FY2024, which is N/A change from last year.
  • Per Neurogene's latest filing, its Assets Average stood at $292.6 million for Q3 2025, which was down 4.48% from $306.3 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Assets Average ranged from a high of $325.5 million in Q1 2025 and a low of $91.8 million during Q3 2023.
  • Moreover, its 3-year median value for Assets Average was $187.6 million (2024), whereas its average is $204.3 million.
  • Data for Neurogene's Assets Average shows a peak YoY spiked of 94.93% (in 2024) over the last 5 years.
  • Over the past 3 years, Neurogene's Assets Average (Quarterly) stood at $156.1 million in 2023, then soared by 60.13% to $249.9 million in 2024, then surged by 70.13% to $292.6 million in 2025.
  • Its Assets Average stands at $292.6 million for Q3 2025, versus $306.3 million for Q2 2025 and $325.5 million for Q1 2025.